RNA, U6 small nuclear 672, pseudogene (RNU6-672P)

RNA, U6 small nuclear 672, pseudogene (RNU6-672P) is a non-coding RNA pseudogene derived from the highly conserved U6 small nuclear RNA (snRNA) gene. The functional U6 snRNA is a critical component of the spliceosome complex, which catalyzes intron removal from pre-mRNA during mRNA splicing in eukaryotic cells[1][3]. RNU6-672P, however, is a pseudogene, meaning it is a non-functional copy of the U6 snRNA gene and does not produce a functional RNA molecule. Pseudogenes like RNU6-672P are common in the genome and thought to arise through duplication or retrotransposition events. While there is growing evidence for some pseudogenes having regulatory roles in gene expression, there is no direct evidence that RNU6-672P functions as a protein, regulatory RNA, or therapeutic target. It is not a receptor, enzyme, transporter, or other canonical drug target class. It is not known to interact with drugs, act as a biomarker, or present any therapeutic safety concerns. Its main significance is as a member of the large family of U6-derived pseudogenes found throughout vertebrate genomes[3]. Key clarifications: - This is a pseudogene, not a functional target, and therefore is not therapeutically actionable or classified with typical drug target families. - No evidence links this specific pseudogene to direct roles in disease or therapy, though some pseudogenes may be dysregulated in cancer[2]. - There is nothing inherently incorrect in the name, but as a pseudogene, it is not a functional molecule or therapeutic target; thus, for most drug discovery or target validation pipelines, it is not a relevant entity.

Other names

RNU6-672PU6 snRNA pseudogene 672U6 small nuclear RNA pseudogene 672